Concepedia

Smruthi Vijayaraghavan

SV

Statistics

Publications

8

Citations

1.1K

H-Index

8

Active since

2016

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Smruthi Vijayaraghavan is an author at The University of Texas MD Anderson Cancer Center specializing in tumor biology, cancer genetics, and drug discovery.

ORCID

Top concepts

Publications per year

2016–2020

8

Publications

8

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

Smruthi Vijayaraghavan, Cansu Karakaş, Iman Doostan et al. · Nature Communications · 2017 · 272 citations · Full text

Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis

Smruthi Vijayaraghavan, Lorraine Lipfert, Kristen Chevalier et al. · Molecular Cancer Therapeutics · 2020 · 190 citations · Full text

Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer

Jason P.W. Carey, Cansu Karakaş, Tuyen Bui et al. · Cancer Research · 2017 · 140 citations · Full text

, , +19

Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

Nicole M. Kettner, Smruthi Vijayaraghavan, Merih Güray Durak et al. · Clinical Cancer Research · 2019 · 132 citations · Full text

Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition

Xian Chen, Kwang-Huei Low, Angela Alexander et al. · Clinical Cancer Research · 2018 · 110 citations · Full text

1–5 of 8